Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.

Blood
Joerg KahleChristoph Königs

Abstract

Several studies showed that neutralizing anti-factor VIII (anti-fVIII) antibodies (inhibitors) in patients with acquired hemophilia A (AHA) and congenital hemophilia A (HA) are primarily directed to the A2 and C2 domains. In this study, the frequency and epitope specificity of anti-C1 antibodies were analyzed in acquired and congenital hemophilia inhibitor patients (n = 178). The domain specificity of antibodies was studied by homolog-scanning mutagenesis (HSM) with single human domain human/porcine fVIII proteins and antibody binding to human A2, C1, and C2 domains presented as human serum albumin (HSA) fusion proteins. The analysis with HSA-fVIII domain proteins confirmed the results of the HSM approach but resulted in higher detection levels. The higher detection levels with HSA-fVIII domain proteins are a result of antibody cross-reactivity with human and porcine fVIII leading to false-negative HSM results. Overall, A2-, C1-, and C2-specific antibodies were detected in 23%, 78%, and 68% of patients with AHA (n = 115) and in 52%, 57%, and 81% of HA inhibitor patients (n = 63). Competitive binding of the human monoclonal antibody (mAb) LE2E9 revealed overlapping epitopes with murine C1-specific group A mAbs including 2A9. Mut...Continue Reading

References

May 4, 2004·BMC Bioinformatics·Shandar AhmadAkinori Sarai
Jun 29, 2004·Journal of Thrombosis and Haemostasis : JTH·P Lollar
May 13, 2006·Journal of Thrombosis and Haemostasis : JTH·M JacqueminM Dewerchin
Dec 22, 2006·Journal of Thrombosis and Haemostasis : JTH·J F HealeyP Lollar
Apr 12, 2007·Journal of Thrombosis and Haemostasis : JTH·P J LentingC V Denis
Jul 3, 2009·Thrombosis and Haemostasis·John F HealeyPete Lollar
Dec 17, 2009·Protein Science : a Publication of the Protein Society·Jane CarterChristopher Mehlin
May 25, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·P M W van HeldenJ Voorberg
Nov 22, 2011·Blood·Charles R M HayUNKNOWN International Immune Tolerance Study
Mar 30, 2012·Lancet·Erik Berntorp, Amy D Shapiro
Jul 13, 2012·Journal of Thrombosis and Haemostasis : JTH·P LapaludG Lavigne-Lissalde

❮ Previous
Next ❯

Citations

Feb 16, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·C H Miller
Aug 8, 2018·Nature Reviews. Clinical Oncology·Kris M MahadeoUNKNOWN Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Jan 27, 2019·Expert Opinion on Drug Safety·Massimo Morfini, Carlo Antonio Paolo Rapisarda
Sep 23, 2020·Hämostaseologie·Andreas Tiede, Lorenzo Alberio
Aug 27, 2019·Journal of Thrombosis and Haemostasis : JTH·Halet TürkantozAndreas Tiede
May 24, 2018·Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne·Romeo-Gabriel Mihăilă
Apr 20, 2021·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Pierre ChamouniChristoph Königs
May 28, 2021·Blood·Gary E Gilbert
Jul 26, 2021·Pathology·Stephanie AndersonGeoff Kershaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.